Search results for "Prostate Cancer"


 
Results 31 - 40 of about 109 for "Prostate Cancer".

FDA approves generic hypertension drugs, looks at Stalevo

because of shortages of propofol injection. The FDA is currently studying whether Stalevo, a Parkinson's disease medication, is associated with an increased risk for developing prostate cancer. ... Researchers unexpectedly found that more patients taking
June 2010

Highlights

Validated tools such as the Expanded Prostate Cancer Index Composite for Clinical Practice may help. ... comprehensive measures of prostate cancer such as the Expanded Prostate Cancer Index Composite for Clinical Practice (EPIC-CP).
June 2014

Letters to the Editor

An Annals of Internal Medicine editorial in the May 5 issue again notes that, “Within 10 years of trial entry, screening increases the number of cancer cases diagnosed but has no ... by overzealous therapies and like to pronounce themselves as
June 2009

Highlights

population-based case-control study of men who were diagnosed with prostate cancer in 2007-2009. ... Risk for prostate cancer was the main outcome measure. The study results were published online by BMJ on June 18.
June 2013

New guidance urges caution on testosterone

Similarly, there is no clear guidance on whether it's safe to treat men who have been successfully treated for prostate cancer, said Dr. ... Elghonemy. “Patients who have undergone prostate cancer treatment often have complaints of sexual dysfunction,
May 2020

Highlights

Men with localized, low-risk prostate cancer should be closely monitored until disease progression warrants treatment, concluded an independent panel of the National Institutes of Health. ... Using this definition, the panel estimated that more than
December 2011

Prostate cancer

The number of men 50 years and older diagnosed with prostate cancer nationwide declined from 213,562 men in 2011 to 180,043 men in 2012. ... An editorial noted concerns about the decline in prostate cancer screening and prostate cancer incidence.
November 2015

Letters to the Editor

Prostate cancer screening leads to unneeded treatments, “ ACP InternistWeekly, March 24. ... And a comment from the body of the article is revealing: “The cumulative death rate from prostate cancer at 10 years in the two groups combined was 25% lower
May 2009

High-value management of patients with GI symptoms

Cheatham. Another etiology of rectal bleeding is radiation proctitis, which typically develops one to two years after radiation exposure in those treated for cervical cancer or prostate cancer, he noted. ... Cheatham. Finally, he said, cancer is an
June 2017

ACP convenes, in person and virtually, for Internal Medicine Meeting 2022

To round out our clinical coverage, read about a urologist's tips on clarifying the conundrum of prostate cancer screening.
July 2022

Prev   1   2   3   4   5   6   7   8   9   10   Next